Patents by Inventor David Bledsoe

David Bledsoe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11752123
    Abstract: An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of Magnolia, an extract of Phellodendron, and a whey protein.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: September 12, 2023
    Assignee: NUTRAMAX LABORATORIES, INC.
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Publication number: 20230157984
    Abstract: An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one of magnolia and an extract of magnolia, and at least one of phellodendron and an extract of phellodendron. The composition may include a combination of an extract of Magnolia officinalis and a extract of Phellodendron amurense. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or ?-aminobutyric acid (GABA).
    Type: Application
    Filed: December 28, 2022
    Publication date: May 25, 2023
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Publication number: 20210137870
    Abstract: An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of Magnolia, an extract of Phellodendron, and a whey protein.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Patent number: 10940130
    Abstract: An anxiolytic composition includes a synergistic combination of an L-theanine and a whey protein composition.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: March 9, 2021
    Assignee: NUTRAMAX LABORATORIES, INC.
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Publication number: 20190290608
    Abstract: An anxiolytic composition includes a synergistic combination of one or more of an extract of magnolia, an extract of phellodendron, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).
    Type: Application
    Filed: June 11, 2019
    Publication date: September 26, 2019
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Patent number: 10335384
    Abstract: An anxiolytic composition includes a synergistic combination of one or more of an extract of magnolia, an extract of phellodendron, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: July 2, 2019
    Assignee: NUTRAMAX LABORATORIES, INC.
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Publication number: 20180000766
    Abstract: An anxiolytic composition includes a synergistic combination of one or more of an extract of magnolia, an extract of phellodendron, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).
    Type: Application
    Filed: September 15, 2017
    Publication date: January 4, 2018
    Inventors: Todd Henderson, David Griffin, David Bledsoe
  • Patent number: 8352310
    Abstract: A method and system for monitoring enterprise system performance in which a datastore receives and stores performance metric data from different enterprise systems and provides the performance metric data to a web-based browser interface for presentation to a user as one or more linked web pages. In a preferred embodiment, the linked web pages are accessible on an enterprise intranet.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: January 8, 2013
    Assignee: Sprint Communications Company L.P.
    Inventors: James E. Bessler, David Bledsoe, James T. Deel
  • Publication number: 20070020335
    Abstract: The present invention provides pharmaceutical compositions for controlled release of pharmaceutically active agents, especially those with a high water solubility, high dose, and/or short half-life. In addition, the present application provides methods for preparing and using such pharmaceutical compositions.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 25, 2007
    Applicant: Farnam Companies, Inc.
    Inventors: Andrew Chen, David Bledsoe